Aptevo Therapeutics (APVO) Other Gross PP&E Adjustments (2016 - 2023)
Historic Other Gross PP&E Adjustments for Aptevo Therapeutics (APVO) over the last 9 years, with Q3 2023 value amounting to -$5.8 million.
- Aptevo Therapeutics' Other Gross PP&E Adjustments rose 633.59% to -$5.8 million in Q3 2023 from the same period last year, while for Sep 2023 it was -$5.8 million, marking a year-over-year increase of 633.59%. This contributed to the annual value of $8.3 million for FY2022, which is 3141.96% down from last year.
- According to the latest figures from Q3 2023, Aptevo Therapeutics' Other Gross PP&E Adjustments is -$5.8 million, which was up 633.59% from -$5.6 million recorded in Q2 2023.
- In the past 5 years, Aptevo Therapeutics' Other Gross PP&E Adjustments registered a high of $12.1 million during Q4 2021, and its lowest value of -$6.2 million during Q3 2022.
- Over the past 5 years, Aptevo Therapeutics' median Other Gross PP&E Adjustments value was -$4.0 million (recorded in 2020), while the average stood at -$1.4 million.
- Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first soared by 4163.38% in 2022, then tumbled by 22627.38% in 2023.
- Aptevo Therapeutics' Other Gross PP&E Adjustments (Quarter) stood at $9.1 million in 2019, then rose by 12.02% to $10.2 million in 2020, then rose by 18.58% to $12.1 million in 2021, then crashed by 31.42% to $8.3 million in 2022, then plummeted by 169.9% to -$5.8 million in 2023.
- Its Other Gross PP&E Adjustments was -$5.8 million in Q3 2023, compared to -$5.6 million in Q2 2023 and -$5.3 million in Q1 2023.